Hemophilia B Without Inhibitor

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Hemophilia B Without Inhibitor trials may be worth asking about

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingPhase 3

NCT05611801

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called marstacimab) for the potential treatment of hemophilia…

Argentina, Australia +16 more100 participantsStarted 2022-12-09Updated 2026-05-07

Treatment: marstacimab

RecruitingPhase 3

NCT05145127

Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

Study B7841007 is an open-label extension study to assess the long-term safety, tolerability, and efficacy of prophylaxis treatment with marstacimab in particip…

United States, Argentina +22 more245 participantsStarted 2021-11-17Updated 2026-04-14

Treatment: PF-06741086

All recent trials (12 shown)

By InvitationNot Applicable

NCT06831734

Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo

The purpose of the study is to investigate the safety and effectiveness of Alhemo in participants under real-world clinical practice in Japan. Total duration of…

Japan30 participantsStarted 2025-05-02Updated 2026-06-15

Treatment: Concizumab

Active — Not RecruitingPhase 3

NCT04082429

Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors

This study will test how well a new medicine called concizumab works in the body of people with haemophilia A or B without inhibitors. The purpose is to show th…

United States, Algeria +31 more156 participantsStarted 2019-11-13

Hemophilia B Without Inhibitor

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

All recent trials (12 shown)

Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo

Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

All recent trials (12 shown)

Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo

Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors

Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without Inhibitors

Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Se…

ATHN 7: Hemophilia Natural History Study

Safety and Efficacy of STSP-0601 in Adult Patients With Hemophilia A or B Without Inhibitor

Safety and Efficacy Clinical Study of Severe Hemophilia B Treatment With KL001

Safety and Efficacy Clinical Study of Severe Hemophilia B Treatment With KL001

ATHN 8: Previously Untreated Patients (PUPs) Matter Study

Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia